Biocompatibility of Cardiovascular Gene Delivery Catheters with Adenovirus Vectors: An Important Determinant of the Efficiency of Cardiovascular Gene Transfer
Open Access
- 31 May 2000
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 1 (5) , 423-429
- https://doi.org/10.1006/mthe.2000.0059
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Expression of vascular endothelial growth factor and angiogenesis in cardiac myxoma: A study of fifteen patientsThe Journal of Thoracic and Cardiovascular Surgery, 2000
- Six-Month Assessment of a Phase I Trial of Angiogenic Gene Therapy for the Treatment of Coronary Artery Disease Using Direct Intramyocardial Administration of an Adenovirus Vector Expressing the VEGF121 cDNAAnnals of Surgery, 1999
- Intraoperative Multiplane Transesophageal Echocardiography for Guiding Direct Myocardial Gene Transfer of Vascular Endothelial Growth Factor in Patients with Refractory Angina PectorisHuman Gene Therapy, 1999
- Angiogenesis Gene TherapyCirculation, 1999
- Gene Therapy for Myocardial AngiogenesisCirculation, 1998
- Angiogenesis and Vasculogenesis in Treatment of Cardiovascular DiseaseMolecular Medicine, 1998
- In Vivo Gene Transfer: A Biological ToolAnnals of the New York Academy of Sciences, 1997
- Molecular Therapies for Vascular DiseasesScience, 1996
- Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty.Journal of Clinical Investigation, 1995
- Gene Therapy for Cardiovascular DiseaseCirculation, 1995